Cited by 51Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on BehaviorOpioid Use Disorder Treatment

A review of addiction

Clay, Steven·2008·Postgraduate Medicine

Abstract

Addiction to drugs and alcohol is often undiagnosed and untreated. Physicians are often unaware or have negative attitudes regarding these patients, such as the perception that treatment is ineffective. Addiction--psychological dependence with or without tolerance and withdrawal--is essentially compulsive uncontrolled substance use despite physical, psychological, or social consequences. We now have an understanding of the 2 major neurological pathways involved in addiction. First, the mesolimbic dopamine reward pathway, which is essential for survival, can be physically altered by drug abuse to result in uncontrolled cravings. Second, the decision-making prefrontal cortex, which suppresses inappropriate reward response, can also be altered by drug abuse. Thus, accelerated "go" signals and impaired "stop" signals result in uncontrolled use despite severe consequences. Further, addicts can be predisposed to addiction by genetic defects in reward pathway neurotransmission and stress-related developmental brain abnormalities. Relapse to drug use can occur because of stress or cue-related reward pathway stimulation or even by a single drug dose. Individualized treatment of addiction, including pharmacological and cognitive-behavioral interventions, can be as successful as treatment of other chronic diseases. Several pharmaceuticals are available or under study for these disorders. Waiting for the addict to "be ready" for treatment can be dangerous and detoxification alone is often ineffective. The physician's role in treating addiction includes prevention, diagnosis, brief intervention, motivational interviewing, referral, and follow-up care. An understanding of the biological reality of addiction allows physicians to understand addicts as having a brain disease. Further, the reality of effective pharmacological and cognitive-behavioral treatments for addiction allows physicians to be more optimistic in treating addicts. The challenge to the physician is to embrace the reality of addictive disease and fulfill his or her role in its treatment.

Integrity signals

Registry

Crossref · 10.3810/pgm.2008.07.1802

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The two most commonly used psychotherapeutic approaches to addiction therapy are motivational interviewing and cognitive behavioral therapy.

    “The two most commonly used psychotherapeutic approaches to addition therapy are motivation interview therapy (Hettema et al., 2005) and cognitive behavioral therapy (Clay et al., 2008).”

    From Impulsivity, frontal lobes and risk for addiction (2009) · cites this paper as Clay et al., 2008

Cited by

Sorted by citations

Authors
Clay, S.
Affiliations
Ohio University (US)
Corresponding author
Clay, Steven
Venue
Postgraduate Medicine
Published
2008-07-15
Volume
120
Issue
2
Pages
E01-7
ISSN
  • 0032-5481 (ISSN-L)
  • 1941-9260
OpenAlex
W1995971654
Cited by
51
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 1 · 2021: 1 · 2020: 4 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 2 · 2013: 3 · 2012: 2
FWCI
4.19
Type
journal article
Language
en
Open access
closed
Locations
  • Postgraduate Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
addiction, substance use disorders, drug addiction, alcoholism, prefrontal cortex, decision-making, relapse, genetic predisposition to addiction, stress, pharmacotherapy, cognitive behavioral therapy, motivational interviewing, brief intervention
MeSH terms
Dopamine, Humans, Limbic System, Mesencephalon, Risk Factors, Behavior, Addictive, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review